Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)

China · Delayed Price · Currency is CNY

15.73

+0.42 (2.74%)

Jul 3, 2026, 3:04 PM CST

-19.74% (1Y)

Market Cap	7.14B -25.5%
Revenue (ttm)	3.40B +6.1%
Net Income	392.31M +20.2%
EPS	0.86 +21.5%
Shares Out	454.07M
PE Ratio	18.21
Forward PE	16.12
Dividend	0.40 (2.54%)
Ex-Dividend Date	May 13, 2026

Volume	4,271,900
Open	14.86
Previous Close	15.31
Day's Range	14.86 - 15.82
52-Week Range	13.91 - 24.03
Beta	0.25
Analysts	Buy
Price Target	20.41 (+29.75%)
Earnings Date	Aug 26, 2026

About SHE:300119

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products. The company provides vaccines, chemical drugs, traditional Chinese medicines; feed additives, including pigs, chickens, waterfowl, cattle, sheep and pet medicines, and vaccines; and poultry, waterfowl, livestock, rumination, pets, washing and disinfection, active pharmaceutical ingredients product series. It also offers diagnosis an... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1998

Employees 2,803

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300119

Full Company Profile

Financial Performance

In 2025, SHE:300119's revenue was 3.40 billion, an increase of 10.70% compared to the previous year's 3.07 billion. Earnings were 400.51 million, an increase of 33.18%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 300119 stock is "Buy." The 12-month stock price target is ¥20.41, which is an increase of 29.75% from the latest price.

Price Target

¥20.41

(29.75% upside)

Analyst Consensus: Buy

Stock Forecasts